About Mitapivat
Class: | Pyruvate kinase activator
Use: | Treatment of hemolytic anemia in adults with pyruvate kinase deficiency
Adult dose: | 20 mg orally twice daily
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Fatigue, headache, dizziness, nausea, diarrhea, abdominal pain
Contraindications: | Hypersensitivity to mitapivat or any component of the formulation; severe hepatic impairment
Storage: | Store at 20°C to 25°C (68°F to 77°F); protect from mois
Drug Class
Pyruvate kinase activator
Uses & Indications
Treatment of hemolytic anemia in adults with pyruvate kinase deficiency
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture
Manufacturer & Packaging
Manufacturer: AGIOS PHARMACEUTICALS INC., United States of America
Package Size
56's
Price & Supplier
Price in UAE: AED 133481.60
Dosage Information
Adult Dose
20 mg orally twice daily
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Fatigue, headache, dizziness, nausea, diarrhea, abdominal pain
Contraindications & Precautions
Hypersensitivity to mitapivat or any component of the formulation; severe hepatic impairment
Important Warnings
Risk of thromboembolic events; monitor for signs of thrombosis; not recommended for use in patients with severe liver disease or those with a history of thromboembolic events
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.